Coronavirus India lockdown Day 203 updates: Theatres to reopen in Delhi, Lucknow


    Coronavirus India lockdown Day 203 updates: Theatres to reopen in Delhi, Lucknow

    India is likely to overtake the U.S. as the country with most number of coronavirus cases worldwide.

    As a part of Unlock 5, cinema halls, entertainment parks, and swimming pools for sportspersons are being reopened on Thursday after months of uncertainty triggered by the coronavirus pandemic.

    While theatres and multiplexes will remain closed in states like Maharashtra, Tamil Nadu, Kerala and Chhattisgarh, they will open this week in several places, including Delhi and parts of Madhya Pradesh and Gujarat, with stringent dos and don’ts in keeping with the new COVID-19 normal.

    You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.

    Here are the latest updates:

    India’s case tally

    67,735 new cases take India’s virus tally to 73,07,097

    India’s COVID-19 tally of cases climbed to 73.07 lakh with 67,735 new cases in a day, while 63,83,441 people have recuperated so far pushing the national recovery rate to 87.35% on Thursday, according to the Union Health Ministry data.

    The total coronavirus cases mounted to 73,07,097 and the death toll climbed to 1,11,266 with the novel coronavirus virus claiming 680 lives in a span of 24 hours in the country, the data updated at 8 a.m. showed. – PTI

    Vaccine update

    Russia approves 2nd coronavirus vaccine after early trials

    Russian authorities have given regulatory approval to a second coronavirus vaccine after early-stage studies, two months after a similar move prompted widespread criticism from scientists both at home and abroad.

    Watch | All about Russia’s Sputnik V vaccine

    The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested among 100 volunteers in early-stage, placebo-controlled human trials, which lasted more than two months and were completed two weeks ago. The volunteers were between 18 and 60 years old.

    The scientists have yet to publish the results of the study. In comments to the media, scientists developing the vaccine said that it produced enough antibodies to protect the person who had it from the virus and that the immunity it creates could last for up to six months.

    Focusing on protecting people, health of population remain a priority for India: IMF

    India’s priorities should be to protect the most vulnerable people, well targeted support and protecting small and medium sized enterprises so that they do not collapse as the country battles the COVID-19 pandemic, Managing Director of the International Monetary Fund Kristalina Georgieva has said.

    A day earlier, the IMF in its annual World Economic Report said that the forecast are particularly large for India, where Gross Domestic Product (GDP) contracted much more severely than expected in the second quarter. – PTI

    (the headline, this story has not been published by Important India News staff and is published from a syndicated feed.)


    Please enter your comment!
    Please enter your name here